RSSRelated Content
A course for nurses on smoking prevention and cessation
Un cours pour les infirmières sur prévention et l’abandon du tabac
2025 CIHR Team Grant: Bringing Biology to Cancer Prevention
On February 26, 2026, the Honourable Marjorie Michel, Minister of Health, announced that the Government of Canada and partners are investing over $41 million in groundbreaking cancer prevention research through this program. This funding will support 19 multidisciplinary research teams across Canada working over the next five years to develop new approaches to reduce cancer risk and improve early detection. This funding opportunity is led by Canadian Institutes of Health Research (CIHR) in partnership with the Terry Fox Research Institute, the Canadian Cancer Society, the Japan Agency for Medical Research and Development, the Cancer Research Society, and BioCanRx. As part of this national initiative, the research aims to generate new biological insights that could accelerate cancer prevention strategies. Dr. Michael Pollak, Professor at McGill University and Director of the Cancer Prevention Centre, has been awarded a CIHR Team Grant: Bringing Biology to Cancer Prevention, with his application ranked first in the national competition. The five-year project, titled “Incretin-mimetic drugs for cancer prevention: Mechanisms and clinical potential,” will receive nearly $2 million in funding (2025–2030) to investigate whether medications used to treat obesity and type 2 diabetes, such as incretin-mimetics, could also help reduce cancer risk.
FRQS Chercheurs-boursiers Cliniciens Junior 1 award
Congratulations to Dr. Stephanie Wong for receiving this award for her program focusing on optimizing decision making and prevention strategies in women at high risk for developing breast cancer
Les Prix du Québec 2020
Congratulations to Dr. Will Foulkes, who has been awarded Quebec’s highest science award; we are proud to have him on the CPC team!
2019 awards and research funding
Dr. Pollak was elected to be a fellow of the Royal Society of Canada (RSC). He is also Co-Leader of the Stand Up To Cancer (SU2C) Canada Metastatic Breast Cancer Dream Team.
Appointed Co-Editor-in-Chief of Cancer Prevention Research - AACR Journal
The American Association for Cancer Research (AACR) has appointed Dr. Pollak as Co-Editor-in-Chief of Cancer Prevention Research, an international journal published by AACR, effective January 1, 2019.
O. Harold Warwick Prize by the Canadian Cancer Society
Consecutive national recognition of work in cancer genetics and prevention at McGill and the Jewish General Hospital! Dr. Michael Pollak was awarded the prestigious O. Harold Warwick Prize by the Canadian Cancer Society in 2012 and Dr. William Foulkes received it in 2013. This prize is given to "A scientist whose research has had a major impact on cancer control". Nominations are received from across Canada, so we are proud that two of our senior clinician scientists with neighboring offices in the same institution captured the award two years in a row, reflecting national recognition of our research work.
Your Cancer Risk
Try this interactive website and see if you are at risk of developing any of the 12 most common types of cancer. It also gives tips on how to lower your cancer risk.
Dr. Michael Pollak's Publications
To access Dr. Pollak's publications, please visit the McGill Pollak Research Lab.
Dr. Pollak's Assay Lab
Dr. Pollak's assay lab specializes in hormone and peptide biomarker measurements of serum or plasma samples for biomedical research using ELISA methods, with over 15 years of experience providing assay services to a variety of users. For more information on the lab's ELISA assay capabilities, collaborators, projects, and publications, please visit Dr. Pollak's Assay Lab.